126 57
English Pages [614] Year 2017
Essentials in HEMATOLOGY AND CLINICAL PATHOLOGY
Essentials in HEMATOLOGY AND CLINICAL PATHOLOGY Second Edition
Ramadas Nayak
MBBS MD
Professor and Head Department of Pathology Yenepoya Medical College Yenepoya University Mangaluru, Karnataka, India Formerly, Head Department of Pathology Kasturba Medical College Manipal University Mangaluru, Karnataka, India
Sharada Rai
MBBS MD
Associate Professor Department of Pathology Kasturba Medical College Manipal University Mangaluru, Karnataka, India
Foreword K Ramnarayan
The Health Sciences Publisher New Delhi | London | Philadelphia | Panama
Jaypee Brothers Medical Publishers (P) Ltd Headquarters Jaypee Brothers Medical Publishers (P) Ltd 4838/24, Ansari Road, Daryaganj New Delhi 110 002, India Phone: +91-11-43574357 Fax: +91-11-43574314 Email: [email protected]
Overseas Offices J.P. Medical Ltd 83 Victoria Street, London SW1H 0HW (UK) Phone: +44 20 3170 8910 Fax: +44 (0)20 3008 6180 Email: [email protected]
Jaypee-Highlights Medical Publishers Inc City of Knowledge, Bld. 235, 2nd Floor, Clayton Panama City, Panama Phone: +1 507-301-0496 Fax: +1 507-301-0499 Email: [email protected]
Jaypee Medical Inc 325 Chestnut Street Suite 412, Philadelphia PA 19106, USA Phone: +1 267-519-9789 Email: [email protected]
Jaypee Brothers Medical Publishers (P) Ltd 17/1-B Babar Road, Block-B, Shaymali Mohammadpur, Dhaka-1207 Bangladesh Mobile: +08801912003485 Email: [email protected]
Jaypee Brothers Medical Publishers (P) Ltd Bhotahity, Kathmandu, Nepal Phone: +977-9741283608 Email: [email protected] Website: www.jaypeebrothers.com Website: www.jaypeedigital.com © 2017, Jaypee Brothers Medical Publishers The views and opinions expressed in this book are solely those of the original contributor(s)/author(s) and do not necessarily represent those of editor(s) of the book. All rights reserved. No part of this publication may be reproduced, stored or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission in writing of the publishers. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book. Medical knowledge and practice change constantly. This book is designed to provide accurate, authoritative information about the subject matter in question. However, readers are advised to check the most current information available on procedures included and check information from the manufacturer of each product to be administered, to verify the recommended dose, formula, method and duration of administration, adverse effects and contraindications. It is the responsibility of the practitioner to take all appropriate safety precautions. Neither the publisher nor the author(s)/editor(s) assume any liability for any injury and/ or damage to persons or property arising from or related to use of material in this book. This book is sold on the understanding that the publisher is not engaged in providing professional medical services. If such advice or services are required, the services of a competent medical professional should be sought. Every effort has been made where necessary to contact holders of copyright to obtain permission to reproduce copyright material. If any have been inadvertently overlooked, the publisher will be pleased to make the necessary arrangements at the first opportunity.
Inquiries for bulk sales may be solicited at: [email protected] Essentials in Hematology and Clinical Pathology First Edition: 2012 Second Edition: 2017 ISBN 978-93-5152-423-6 Printed at
Dedicated to Students who inspired us, patients who provided the knowledge, our parents and family members who encouraged and supported us.
Foreword
“Some books are to be tasted, others swallowed and some few to be chewed and digested,” said Francis Bacon. This book, for which I am delighted to write the Foreword, has to be not merely tasted, chewed, swallowed and digested but also absorbed and assimilated for best results! Clarifying concepts and inculcating the foundational tenets in hematology and clinical pathology are daunting tasks for any teacher. The teachers who have authored this book have admirably captured the core of the subject capping that with lucid explanations. The authors have expertize not only in the subject but also in the art of teaching. Willingness to share and the ability to convey convincingly are the veritable attributes of the authors. It is this wisdom of experience and expression that has percolated into this book. A book of this substance and style was long overdue and it could not have been timelier. I am certain that the contents of the book will mellow with each succeeding edition in the years to come. Let me congratulate and commend the authors for the pains they took to bring out a book, which deserves much more than just having a look.
K Ramnarayan MBBS MD (Path) PG Dip. Higher Education
Vice-Chancellor Manipal University Manipal, Karnataka, India
Preface to the Second Edition Hematology is one of the rapidly expanding fields of medicine with new techniques. An extensive amount of time and effort is spent by the students in going through large volumes of various hematology textbooks. Hence, this second edition is a comprehensive book that has retained the total number of pages same as in the first edition and has also included updates on recent changes in hematology. Chapter 49 is renamed as “Automation in Hematology” and principles and uses of automations have been dealt with. A new Chapter 67 “Clinical Scenario” is added to help the student to solve the clinical-oriented questions asked in a few university examinations. New appendix 2 with laboratory values of clinical importance is also added. Understanding hematology requires insight into the applied physiology and the pathophysiologic basis of these diseases in the context of relevant clinical features which is often neglected. Essentials in Hematology and Clinical Pathology emphasizes on building a strong foundation of both concepts. Clinical pathology section of the book deals with both hematological and nonhematological laboratory investigations done in routine practice. The book has been organized into four sections namely Disorders of Red Cells, Disorders of White Cells, Disorders of Hemostasis and Clinical Pathology. Essentials in Hematology and Clinical Pathology also features: •• Molecular basis of common hematological disorders •• About 135 illustrations, 27 photomicrographs, 18 photographs and 146 tables have been provided to facilitate easy and quick learning. Some of the illustrations and photomicrographs have been improved in quality •• A summary of the important points at the end of each chapter •• Essay questions, short note questions and more than 300 multiple choice questions (MCQs) to encourage self-evaluation of the important concepts by the students •• Recent WHO classification (2016) of Tumors of Hematopoietic and Lymphoid Tissues We hope that the textbook will provide a foundation to the students in hematology and clinical pathology and improve their understanding of the subject.
Ramadas Nayak Sharada Rai
Preface to the First Edition Hematology is one of the rapidly expanding fields of medicine. The extensive amount of time and effort spent by the students in going through volumes of the hematology textbooks encouraged us to write this comprehensive book. Understanding hematology requires insight into the applied physiology and the pathophysiologic basis of these diseases in the context of relevant clinical features which is often neglected. Essentials in Hematology and Clinical Pathology emphasizes on building a strong foundation of both concepts. Clinical pathology section of the book deals with both hematological and nonhematological laboratory investigations done in routine practice. The book has been organized into four sections namely Disorders of Red Cells, Disorders of White Cells, Disorders of Hemostasis and Clinical Pathology. Essentials in Hematology and Clinical Pathology also features: •• Molecular basis of common hematological disorders •• About 135 illustrations, 27 photomicrographs, 18 photographs and 146 tables have been provided to facilitate easy and quick learning •• A summary of the important points at the end of each chapter •• Essay questions, short note questions and 351 MCQs to encourage self-evaluation of the important concepts by the students •• Recent WHO classification (2008) of Tumors of Hematopoietic and Lymphoid Tissues. We hope that the textbook will provide a foundation to the students in hematology and clinical pathology and improve their understanding of the subject.
Ramadas Nayak Sharada Rai Astha Gupta
Acknowledgements First and foremost, we wish to express our respects and deep gratitude to Dr Astha Gupta, for having been the author for the first edition of this book. Our sincere thanks to Ms Prathibha Bhat, for her untiring efforts, patience and excellent support in creating the illustrations for the first edition of this book. •• We wish to express our gratitude to Mr Yenepoya Abdulla Kunhi, Honorable Chancellor, and Mr Farhaad Yenepoya, Director of Finance, Yenepoya University (Accredited by NAAC with “A” grade), Mangaluru, Karnataka, India, for their inspiration and encouragement. •• We are grateful to Dr K Ramnarayan, former Vice-Chancellor, Manipal University, Manipal, Karnataka, for writing the foreword for the first edition, and encouragement and support. •• We also wish to thank all our family members including Smt Rekha Nayak, Ms Rashmitha Nayak, Mr Ramnath Kini, Master Rishab Kini, Mr Ravidas Nayak (Engineer, Bengaluru), Dr Narendra Shetty, Master Jagrath, who have patiently accepted our long preoccupation with this work. Our sincere gratitude to our parents who will always remain our guiding light. We would like to express our gratitude to all our friends, undergraduate and postgraduate students (Department of Pathology, Yenepoya Medical College, Mangaluru) and colleagues, who helped, inspired and supported us in the different stages of preparing the manuscript; to all those who provided support, talked things over, read, offered comments and assisted in the editing, proofreading and design. •• Dr Rakshatha Nayak, Tutor, Department of Pathology, Yenepoya Medical College, a constituent of Yenepoya University (Accredited by NAAC with “A” grade), Mangaluru. •• We are thankful to all our friends Dr Krishnaraj Upadhyaya (Professor), and Dr Krishna Prasad HV (Assistant Professor), Department of Pathology, Yenepoya Medical College, a constituent of Yenopoya University (Accredited by NAAC with “A” grade), Mangaluru. •• A special thanks to Shri Jitendar P Vij (Group Chairman), Mr Ankit Vij (Group President), Mr Tarun Duneja (Director–Publishing), and Ms Chetna Malhotra Vohra (Associate Director–Content Strategy) of M/s Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India, for publishing the book in the same format as wanted, well in time. We are grateful to Shri Jitendar P Vij, for unmasking our talent as authors. •• We would like to offer a huge appreciation to the wonderful work done by Ms Sunita Katla (Publishing Manager), Ms Samina Khan (Executive Assistant to Director–Publishing), Mr Rajesh Sharma (Production Coordinator), Ms Seema Dogra (Cover Designer), Mr Laxmidhar Padhiary (Proofreader), Mr Rajesh Ghurkundi (Graphic Designer) and Mr Raj Kumar (DTP Operator) of M/s Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India. •• We thank especially Mr Venugopal V (Bengaluru) and Mr Vasudev H (Mangaluru) of M/s Jaypee Brothers Medical Publishers (P) Ltd, Bengaluru Branch, Karnataka, for taking this book to every corner of Karnataka. •• Last but definitely not least, a thank you to our undergraduate and postgraduate students. Without you, we would not write. You make all our books possible. There are many more people we could thank, but space, and modesty compel us to stop here.
Contents SECTION 1
Disorders of Red Cells 1. Introduction
Definition 3 Hematopoiesis 4
2. Classification of Anemia
57
b-Thalassemia 58 a-Thalassemia 66
8. Sickle Cell Disease
51
Hereditary spherocytosis 52 Hereditary elliptocytosis 55
7. Thalassemia Syndromes
41
Hemolytic anemia 43 Classification of hemolytic anemias 49
6. Hemolytic Anemias due to Red Cell Membrane Disorders
24
Metabolism of vitamin B12 and folic acid 25 Etiology of megaloblastic anemia 28 Laboratory findings of megaloblastic anemia 29 Anemias of vitamin B12 deficiency 33 Anemia of folate deficiency 38 Nonmegaloblastic causes of macrocytic anemias 39
5. Introduction and Classification of Hemolytic Anemia
14
Iron metabolism 14 Iron deficiency anemia 17
4. Megaloblastic Anemia
9
Red cell 9 Anemia 10
3. Iron Deficiency Anemia
3
Sickle cell anemia 70 Sickle cell trait 78 Other sickling syndromes 79 Other hemoglobinopathies 80
69
xvi
Essentials in Hematology and Clinical Pathology
9. Hemolytic Anemias due to Red Cell Enzyme Deficiencies
Metabolic pathways in red blood cells 83 Glucose-6-phosphate dehydrogenase deficiency 84 Pyruvate kinase deficiency 87
10. Immunohemolytic Anemia
117
Hereditary sideroblastic anemias 118 Acquired idiopathic sideroblastic anemia 119 Congenital dyserythropoietic anemias 119
17. Approach to Anemias
112
Anemia of chronic disease 112 Anemia of renal disease 114 Anemia of liver disease 114 Anemias of blood loss 114 Anemia associated with marrow infiltration (myelophthisic anemia) 115
16. Sideroblastic Anemia
110
Definition 110 Etiology 110 Clinical features 110 Laboratory findings 111
15. Miscellaneous RBC Disorders
104
Definition 104 Etiology 104 Pathogenesis 105 Clinical features 106 Laboratory findings 107
14. Pure Red Cell Aplasia
100
Definition 100 Etiology and pathogenesis 100 Clinical features 101 Laboratory findings 102
13. Aplastic Anemia
98
Classification 98 Laboratory findings 99
12. Paroxysmal Nocturnal Hemoglobinuria
89
Alloimmune hemolytic anemia 89 Autoimmune hemolytic anemia 92
11. Fragmentation Syndrome
83
Approach to the diagnosis of anemia 121 Approach to the diagnosis of hemolytic anemia 125
121
Contents
SECTION 2
Disorders of White Cells 18. Quantitative and Qualitative Disorders of White Blood Cells
Classification of WBC disorders 131 Quantitative disorders of leukocytes 132 Qualitative disorders of leukocytes 138
19. Infectious Mononucleosis
182
Chronic myelogenous leukemia 182 Myelodysplastic/myeloproliferative neoplasms 189
26. Polycythemia
176
Essential thrombocythemia 177 Primary myelofibrosis 178
25. Chronic Myelogenous Leukemia and Other Myeloid Neoplasms
170
Definition 170 Classification 170 Etiology and molecular pathogenesis 172 Clinical features 173 Laboratory findings 173
24. Myeloproliferative Neoplasm
164
Acute myelogenous leukemia 164 Myeloid sarcoma 167
23. Myelodysplastic Syndromes
158
Acute lymphoblastic leukemia 158 Acute lymphoblastic lymphoma 162
22. Acute Myelogenous Leukemia and Related Neoplasm
147
Neoplastic proliferations of white cells 147 Acute leukemia 148
21. Acute Lymphoblastic Leukemia
141
Definition 141 Pathogenesis 141 Clinical features 143 Laboratory findings 144 Lesions associated with EBV infection 146
20. Introduction to Acute Leukemia
129
Polycythemia vera 193
192
xvii
xviii
Essentials in Hematology and Clinical Pathology
27. Chronic Lymphocytic Leukemia and Other Lymphoid Leukemias
197
Chronic lymphocytic leukemia 197 Prolymphocytic leukemia 201 Hairy cell leukemia 202
28. Plasma Cell Neoplasms
Multiple myeloma (plasma cell myeloma) 207 Plasmacytoma 215 Immunoglobulin deposition diseases 216 Monoclonal gammopathy of uncertain significance 216 Osteosclerotic myeloma 216
29. Lymphopoietic System
206
219
Lymph nodes 219 Development of lymphocytes (lymphopoiesis) 221
30. Lymphoid Neoplasms
226
Classification of lymphoid neoplasms 227 Precursor lymphoid neoplasms 228 Mature B cell neoplasms 228 Mature T cell and NK cell neoplasms 240
31. Hodgkin Lymphoma
247
Classical Hodgkin lymphoma 251 Nodular lymphocyte predominant Hodgkin lymphoma 256 Etiology and pathogenesis of Hodgkin lymphoma 258 Laboratory findings 259 Clinical features 260
32. Langerhans Cell Histiocytosis
264
Definition 264 Morphology 264 Laboratory findings 265
SECTION 3
Disorders of Hemostasis 33. Normal Hemostasis and its Components
Platelets 269 Blood vessel wall 270 Coagulation system 271 Coagulation regulatory mechanism 274 Fibrinolytic system 275 Normal hemostasis 276
269
Contents
34. Bleeding Disorders: Vessel Wall Abnormalities
280
Disorders of hemostasis 280 Bleeding disorders caused by vessel wall abnormalities 283
35. Bleeding Disorders: Abnormalities of Platelet
286
Quantitative platelet disorders 286 Qualitative platelet disorders 296
36. Bleeding Disorders: Abnormalities of Coagulation Factors
300
Hereditary deficiencies 301 Acquired coagulation disorders 306 Disseminated intravascular coagulation 307
37. Thrombotic Disorders: Hypercoagulable States
313
Inherited hypercoagulable states 314 Acquired hypercoagulable states 315
SECTION 4
Clinical Pathology 38. Anticoagulants and Collection of Blood
39. Hematopoiesis
329
Erythropoiesis 329 Myelopoiesis 331 Megakaryopoiesis 333
40. Hemoglobin Estimation
321
Anticoagulants 321 Steps in hematological investigation 323
335
Indications for hemoglobin estimation 335 Methods of hemoglobin estimation 335
41. Cell Count
343
Red blood cell count 345 Total WBC count 347 Platelet count 349 Absolute eosinophil count 351
42. Peripheral Blood Smear Examination
Stains for blood smear 354 Preparation of the peripheral blood smear 355 Fixation of the smear 356 Staining of the smear 356 Examination of a peripheral blood smear 357
354
xix
xx
Essentials in Hematology and Clinical Pathology
43. Reticulocyte Count
Methods of reticulocyte count 366 Significance of reticulocyte count 368
44. Hematocrit, Red Cell Indices and ESR Estimation
418
Collection of urine specimen 418 Preservation of urine 419 Examination of urine 419 Physical examination 419 Chemical examination 424 Microscopic examination 439
51. Body Fluids
408
Automated hematology analyzer 408 Flow cytometry 415
50. Urine Analysis
394
Tests for platelet component 395 Tests for platelet and vascular component 396 Tests for coagulation component 398 Tests for fibrinolytic activity 402
49. Automation in Hematology
390
Definition 390 Myeloperoxidase 390 Sudan black B 391 Nonspecific esterase 391 Periodic acid-Schiff reaction 391 Neutrophil alkaline phosphatase 392
48. Laboratory Evaluation of Hemostatic and Thrombotic Disorders
387
Procedure 387 Interpretation 388
47. Cytochemistry in Leukemia
381
Bone marrow aspiration 381 Bone marrow trephine biopsy 384
46. Osmotic Fragility Test
370
Hematocrit 370 Red cell (erythrocyte) indices 373 Erythrocyte sedimentation rate 375 Lupus erythematosus cell test 378
45. Bone Marrow Examination
366
Examination of body fluids 447 Examination of synovial fluids 448
446
Contents
52. Cerebrospinal Fluid Examination
Importance of CSF examination 451 Collection of CSF 451 Examination of CSF 453
53. Semen Analysis
499
Blood transfusion 499 Blood components 503 Transfusion reactions 505 Exchange transfusion 508
61. Hematopoietic Stem Cell Transplantation
495
Direct antiglobulin test 495 Indirect antiglobulin test 497
60. Transfusion Medicine
487
ABO blood group system 487 Rh blood group system 492 Other blood group systems 493
59. Antiglobulin Test
484
Oral glucose tolerance test 484 Glycosuria 486
58. Blood Group System
474
Cytology of female genital tract 477 Cytology of other systems 480 Buccal smear for Barr body 480 FNAC appearance of some common lesions 481
57. Glucose Tolerance Test
470
Sputum collection 470 Examination of sputum 471
56. Cytology
466
Pregnancy tests 466
55. Sputum Examination
457
Different procedures of semen analysis 457 Cryopreservation of spermatozoa 462
54. Pregnancy Test
451
Definition 510 Sources of hematopoietic stem cells 510 Types of hematopoietic stem cell transplant 511 Indications for hematoporetic stem cell transplantation 511 Autologous stem cell transplant 511
510
xxi
xxii
Essentials in Hematology and Clinical Pathology
Allogeneic stem cell transplantation 512 Complications of hematopoietic stem cell transplantation 513
62. Gastric Function Tests
Tests for gastric acid secretion 515 Other tests 516
63, Liver Function Tests and Liver Biopsy
538
Stool examination 539 Stool culture and sensitivity 545
67. Clinical Scenario
533
Thyroid function tests 534
66. Stool Examination
529
Tests for renal function 529 Renal biopsy 531
65. Thyroid Function Tests
518
Liver function tests 518 Liver biopsy 524
64. Renal Function Tests
515
546
Symptoms and signs that suggest a blood disease 546 Patterns strongly suggestive of a blood disease 547
Bibliography 555 Appendices 557
Appendix 1: WHO classification of tumors of hematopoietic and lymphoid tissues 557 Appendix 2: Laboratory values of clinical importance 562
Index 569
1
SECTION
Disorders of Red Cells
1. Introduction 2. Classification of Anemia 3. Iron Deficiency Anemia 4. Megaloblastic Anemia 5. Introduction and Classification of Hemolytic Anemia 6. Hemolytic Anemias due to Red Cell Membrane Disorders 7. Thalassemia Syndromes 8. Sickle Cell Disease 9. Hemolytic Anemias due to Red Cell Enzyme Deficiencies 10. Immunohemolytic Anemia 11. Fragmentation Syndrome 12. Paroxysmal Nocturnal Hemoglobinuria 13. Aplastic Anemia 14. Pure Red Cell Aplasia 15. Miscellaneous RBC Disorders 16. Sideroblastic Anemia 17. Approach to Anemias
1 CHAPTER Introduction
Chapter Outline
□
Definition
□
Hematopoiesis
DEFINITION Hematology is defined as the study of normal antl pathologic aspects of blood and blood cells. Hematopoiesis (hemopoiesis) is the continuous, regulated process of blood cell production or formation. Hematopoietic (hemopoietic) system: It consists of all organs and tissues involved in hematopoiesis, and these are divided into myeloid tissue and lym phoid tissue. The pluripotent hematopoietic stem cell (HSC) is the progenitor of all the cells in blood and gives rise to cells of both myeloid and lymphoid system. 1. The myeloid tissue consists o£bone marrow (medullary cavity) and the cells derived from it, which include: • Red blood cells (RBCs/erythrocytes) • White blood cells (WBCs/leukocytes, except lymphocytes): WBCs consist of: - Granulocytes.: Neutrophils, eosinophils and basophils are collectively called granulocytes because of their different types of cytoplasmic granules. However, the term granulocyte is often referred to only neutrophils. - Monocytes - Lymphocytes (even though included under WBCs; they are lymphoid derived). • Platelets (thrombocytes) Compensatory hyp erplasia: In adults during pathological states, whenever there is an increased demand for blood cells, the bone marrow undergoes compensatory hyp erplasia. This results in replacement of the fatty marrow by hematopoietic tissue. • Extramedullary hematopoiesis: - Normally, the cells of the myeloid lineage arise in the central bone marrow (medullary cavity). If the increased demand of blood cells is not met with compensatory hyp eractivity of marrow alone, hematopoietic islands appear in liver and spleen (resulting in hepatosplenomegaly) and even in lymph nodes.
4
SECTION 1 Disorders of Red Cells –– The myeloid lineage blood cells arising outside the marrow elsewhere in the body are designated as extramedullary hematopoiesis (agnogenic myeloid metaplasia). 2. The lymphoid tissue consists of thymus, lymph nodes and spleen. The common lymphoid progenitor cell gives rise to B cell, T cell and natural killer (NK) cell precursors. They mature to form respective lymphoid cells. The above division of hematopoietic elements as myeloid and lymphoid tissue is mainly for understanding their pathology. It is not always possible to draw clear demarcation between the diseases affecting them.
Functions of Blood Cells
Table 1.1: Main functions of formed elements of blood
Formed elements of blood are red cells, Type of blood cell Main function white cells and platelets. The main Red blood cells Delivery of oxygen to functions of blood cells are presented in tissues Table 1.1. White blood cells Defence against infectious •• As the mature blood elements become organisms old, they are destroyed and constantly Lymphocytes Immune regulation produced to maintain normal periphPlatelets Hemostasis eral blood cell counts. •• In addition, each cell line has the ability to respond appropriately to increased demand like; increased red cell production after blood loss, leukocytosis during infection, wound healing and increased platelet production during chronic bleeding. •• Despite the wide functional diversity of blood cells, all myeloid and lymphoid cells originate from common precursor; pluripotent hematopoietic stem cells (HSC).
HEMATOPOIESIS Sites of Hematopoiesis
Table 1.2: Different sites of hematopoiesis during various phases of life Phase
Period
Site
Yolksac (mesoblastic) phase
First 3 months of gestation
Yolk sac
Terminology Used in Hematopoiesis
Hepatic phase
4–9 months of gestation
Liver (chief site till birth), spleen (minor site)
The meaning of the terms used with reference to hematopoiesis is shown in Table 1.3.
Medullary (myeloid) phase
By 3rd week after birth up to
Bone marrow throughout the skeleton
Adults
Active marrow is limited to the ends of long bones and flat bones
Different sites of hematopoiesis during various phases of life are shown in Table 1.2.
Normal Development of Blood Cells (Hematopoiesis)
puberty
The hematopoietic system is a hierarchy of cells in which pluripotent hematopoietic stem cells proliferate and differentiate. After several steps, HSCs finally give rise to mature blood cells. This hierarchy (Figs 1.1 and 1.2) consists of: 1. Hematopoietic stem cells
CHAPTER 1 Introduction Table 1.3: Different terminologies used with regards to hematopoiesis Terminology Pluripotent
Ability to generate all mature hematopoietic cells
Multipotent
Ability to produce a limited range of differentiated cell lineages appropriate to their location
Unipotent
Restricted ability to differentiate and generate one specific cell type
2. Progenitor cells a. Multipotent progenitor cells b. Committed (unipotent) progenitor cells 3. Precursor cells 4. Maturing and mature cells.
Hematopoietic Stem Cells (HSC) These are small, undifferentiated mononuclear cells that can generate all the blood cell lineages. HSCs possess two fundamental properties: •• Self-renewal: HSCs are capable of cell division to give rise to more stem cells. Fig. 1.1: Cell hierarchy in hematopoiesis •• Differentiation: HSCs can differentiate and give rise to two kinds of lineage-specific multipotent progenitor cells, the common myeloid and the Box 1.1: Stem cell disorders common lymphoid progenitors. •• Chronic myeloid leukemia Note: Apart from blood cells, the stem cells may be •• Polycythemia vera able to differentiate into diverse tissue types (e.g. •• Essential thrombocythemia neuronal, muscle, liver, vascular cells). This change •• Aplastc anemia •• Paroxysmal nocturnal hemoglobinuria in the differentiation of a cell from one type to another is known as transdifferentiation, and the capacity of a cell to transdifferentiate into diverse lineages is referred to as developmental plasticity. Stem cell disorders (Box 1.1).
Progenitor Cells Upon commitment to development, the HSCs enter the next compartment known as progenitor cell compartment. This compartment consists of mainly two types of cells. •• Multipotent progenitor (lineage specific) cells •• Committed (unipotent) progenitor cells Both multipotent and unipotent cells in the bone marrow possess the ability to give rise to clones (groups) composed of specific kinds of mature cells when grown in culture and are called as colony forming units (CFU). Multipotent progenitor cells: These are of two types namely: Early progenitor with myeloid potential and early progenitor with lymphoid potential. •• Early progenitor with myeloid potential further divide to produce mainly two types of multipotent progenitor cells with restricted differentiation. They are:
5
6
SECTION 1 Disorders of Red Cells
Fig. 1.2: Different stages of hematopoiesis (Abbreviations: BFU, burst forming unit; CFU, colony forming unit)
–– CFU b/Mg/E (multipotent) cells which give rise to three types of committed (unipotent) progenitor cells. ◆◆ CFU-E (colony-forming unit-erythrocyte) cells. It is most sensitive to the action of erythropoietin.
CHAPTER 1 Introduction ◆◆ CFU-Mg (colony-forming unit-megakaryocyte) cells ◆◆ CFU-Baso (colony-forming unit-basophil) cells –– CFU-Mix which differentiate into three types of committed (unipotent) progenitor cells. ◆◆ CFU-G (colony-forming unit-granulocyte) cells, precursors of neutrophils ◆◆ CFU-M (colony-forming unit-macrophage) cells, precursors of monocytes and macrophages. ◆◆ CFU-Eo (colony-forming unit-eosinophil) cells, precursors of eosinophils. •• Early progenitor with lymphoid potential cell in turn gives rise to three progenitor cells. –– Pro-T cells which differentiate into T cells. –– Pro-NK cells which differentiate into NK cells. –– Pro-B cells which differentiate into B cells. Lymphocyte development is discussed in Chapter 29. Morphologically, the progenitor (both multipotent and unipotent) cells and stem cells cannot be distinguished from one another on morphological appearance or cytochemistry except by immunological techniques.
Precursor Cells When the immature hematopoietic cell acquires recognizable morphological, cytochemical or immunological feature of a single lineage, it is called as precursor cell. The next step in hematopoiesis is maturation of unipotent progenitor cells to precursor cells. The earliest morphologically recognizable precursor cell of each lineage is termed by adding the suffix “blast” to the type of lineage (e.g. lymphoblast to lymphoid lineage).
Mature Cells The precursor cells finally give rise to mature blood cells, which are released from the marrow into the circulation.
Regulation of Hematopoiesis The growth of different hematopoietic cells is regulated by a number of hematopoietic growth factors, which in general are called cytokines. Most important growth factors acting on various cells are mentioned below. •• Stem cells: Stem cell factor (also called c-KIT ligand), IL-6 and FLT3-ligand. •• CMP progenitor cells: –– Multipotent committed progenitors ◆◆ Granulocyte-macrophage colony-stimulating factor (GM-CSF) ◆◆ Thrombopoietin ◆◆ IL-3, IL-5, IL-6 and IL-11 –– Committed progenitors ◆◆ Erythropoietin (EPO): It is a glycosylated protein synthesized mainly by kidney and minor part from liver. It is produced in response to hypoxia. EPO acts on the erythroid precursors through EPO receptors. This stimulates proerythroblasts to proliferate and differentiate to produce RBCs.
7
8
SECTION 1 Disorders of Red Cells ◆◆ Granulocyte colony-stimulating factor (G-CSF) ◆◆ Thrombopoietin •• Lymphopoiesis is regulated by several interleukins (most important being IL-1, 2, 4, 5, 6, 7, 9). Components of bone marrow are listed in Box 1.2. The characteristic morphologic appearances of various cells of hematopoiesis are discussed in Chapter 39.
Box 1.2: Contents of bone marrow •• Hematopoietic cells –– Myeloid series –– Erythroid series –– Megakaryocytes –– Other cells: Lymphocytes, plasma cells •• Fat tissue •• Vessels •• Nerves •• Reticuloendothelial cells •• Stroma
SUMMARY •• Hematopoiesis is the continuous, regulated process of production of all blood cells. •• Organs and tissues involved in hematopoiesis are known as hematopoietic organs and are divided into myeloid and lymphoid tissue. •• The hematopoietic system is a hierarchy of cells and consists of HSC, multipotent and unipotent progenitors, morphologically identifiable precursors (blast cells) and mature cells. •• Bone marrow is the main site of hematopoiesis after birth and throughout life. •• Under abnormal conditions blood cells may be produced outside the marrow and such production is known as extramedullary hematopoiesis.
SELF-ASSESSMENT EXERCISES I. Short Notes 1. Extramedullary hematopoiesis. 2. Hematopoietic stem cell (HSC). 3. Erythropoietin. 4. Components/contents of bone marrow.
II. Multiple Choice Questions 1. In adults, erythropoiesis occurs mainly in: A. Small bones of hand and feet B. Flat and long bones C. Spleen and lung D. Kidneys and adrenals 2. The cell which has the capacity for self-renewal and pluripotent differentiation is: A. Hematopoietic stem cell B. Progenitor cell C. Precursor cell D. Mature cell 3. The commonest sites of extramedullary hematopoiesis in adult are: A. Liver and spleen B. Kidney and thymus C. Liver and yolk sac D. Lymph node and thymus 4. In the adult, the extramedullary hematopoiesis results in: A. Splenomegaly B. Hyposplenism C. Atrophy of liver D. Atrophy of lymphnodes
Answers 1. B 2. A 3. A 4. A
2
CHAPTER
Classification of Anemia
Chapter Outline
□
Red Cell
□
Anemia
RED CELL Mature red cell is a circular, biconcave disc-containing pigmented protein called hemoglobin and is bound by the cell membrane. On a peripheral blootl smear, they appear as pale red cells with central one-third pallor (where the upper an . lower membrane surfaces closely meet). The advantages of the characteristic morphology of the RBCs are: • The young, healthy red cells are quite flemble and highly deformable so that they can easily pass through extremely narrow capillary beds and splenic sinusoids. They rapidly regain their normal shape after exiting from the capillary bed. • Provides greater surface area compared to volume which allows considerable alterations in the cell volume. Thus the)) can resist hemolysis to certain extent. Aged RBCs become morn-rigid and less deformable and are removed from the circulation in the spleen.
Normal Parameter of Red Cell (Table 2.1) • Size: The size of normal RBCs ranges from 6.7 to 7.7 µm in diameter. • Life span: The average life span of normal RBC is 110-120 days. • Red cell indices (Table 2.1 and for details refer Chapter 44) - Mean cell (corpuscular) volume (MCV): It is the average volume of a red cell and expressed in femtoliters (fL). - Mean cell (corpuscular) hemoglobin (MCH): It represents the average content (mass) of hemoglobin per red cell and expressed in picograms. - Mean cell (corpuscular) hemoglobin concentration (MCHC): It indicates the average concentration of hemoglobin in a given volume of packed red cells and expressed in grams per deciliter. - Red cell distribution width (RDW): RDW is a quantitative measure of anisocytosis and is expressed as percentage.
10
SECTION 1 Disorders of Red Cells Table 2.1: Normal range for red cell and other parameters At birth
Men
Women
Red cell count
5 to 7 million/cu mm (5–7 × 1012/L)
4.5 to 5.5 million/cu mm (4.5–5.5 × 1012/L)
3.8 to 4.8 million/cu mm (3.8–4.8 × 1012/L)
Hemoglobin (Hb)
14–22 g/dL
13–17 g/dL
12–15 g/dL
Hematocrit (Hct) or 45–70% packed cell volume (PCV)
40–50%
36–46%
Reticulocyte count
1–7%
0.5–2.5%
0.5–2.5%
MCV
100–120 fL
82–100 fL
82–100 fL
MCH
31–37 pg
27–32 pg
27–32 pg
MCHC
30–36 g/dL
31–35 g/dL
31–35 g/dL
RDW
13–18%
11.5–14.0%
11.5–14.0%
Red cell indices
ANEMIA Definition of Anemia •• Anemia is defined as the decrease below normal limit (below the reference level for the age and sex of the individual) of the hemoglobin concentration, erythrocyte count or hematocrit (ratio of packed red cells to total blood volume). •• It can also be defined as a reduction of the total circulating red cell mass below normal limits. Red cell mass is the volume of the red cells in the body. Normal red cell mass for men is 26–32 mL/kg and for women is 23–39 mL/kg. •• Functionally, it is defined as the decrease in the oxygen-carrying capacity of the blood, which leads to tissue hypoxia. Anemia is not a disease but it is the expression of underlying disease and from the treatment point of view, it is necessary to identify the cause of anemia. Anemia may be absolute, when there is decreased red blood cell (RBC) mass, or relative, when associated with a higher plasma volume. Relative anemia may occur in the third trimester of pregnancy due to hemodilution (spurious anemia) and is not a disease. But the term anemia is conventionally used for absolute anemia.
Classification of Anemia There are several classifications of anemia. Two commonly used are: 1. Morphological classification (Table 2.2): It is based on: (1) red cell size (normocytic, microcytic, or macrocytic), and (2) degree of hemoglobinization, reflected by the color of red cells (normochromic or hypochromic). 2. Etiological classification: Based on the cause and the underlying mechanisms of production of anemia (Table 2.3).
Clinical Features of Anemia Irrespective of the cause, anemia when severe, presents with certain clinical features. The symptoms depend on four main factors:
CHAPTER 2 Classification of Anemia Table 2.2: Morphological classification of anemia Type of anemia
Microcytic hypochromic
Normocytic normochro- Macrocytic mic
Size of RBCs
Smaller than normal
Normal
Larger than normal
Central pallor in RBCs
More than 1/3
Normal
Normal
Mean corpuscular volume (MCV)
Reduced (100 fL)
Mean corpuscular hemoglobin concentration (MCHC)
Reduced (